Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in Am J Surg Retrieve available abstracts of 51 articles: HTML format

Single Articles

March 2024
1. LEONG D, Leslie C, Laurie B, Hou L, et al
   Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma.
   Am J Surg. 2024 Mar 26:S0002-9610(24)00184-3. doi: 10.1016/j.amjsurg.2024.
   PubMed     Abstract available
   
   
   
2. INNES AM, van Galen P
   Insights from the hereditary endocrine clinic.
   Am J Surg. 2024;229:203-204.
   PubMed    
   
   
   
3. HERRERA M, Hussein MH, Persons E, Alias MR, et al
   Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma.
   Am J Surg. 2024;229:99-105.
   PubMed     Abstract available
   
   
   
4. TRAN A, Weigel RJ, Beck AC
   ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
   Am J Surg. 2024;229:106-110.
   PubMed     Abstract available
   
   
   February 2024
5. SMITH ER, Frye CC, Pandian TK, Gillanders WE, et al
   Molecular characteristics of isthmus papillary thyroid cancers: Supporting evidence for unfavorable clinical behavior.
   Am J Surg. 2024;228:146-150.
   PubMed     Abstract available
   
   
   
6. MONTGOMERY KB, Fazendin JM, Chen H, Broman KK, et al
   Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.
   Am J Surg. 2024;228:173-179.
   PubMed     Abstract available
   
   
   August 2023
7. KUO LE, Suh I
   Can we improve preoperative staging for thyroid cancer?
   Am J Surg. 2023;226:170.
   PubMed    
   
   
   
8. K SAH R, Mayilvaganan S
   "Primary hyperparathyroidism after radioactive iodine therapy. Is it a distinct clinical entity?".
   Am J Surg. 2023;226:296.
   PubMed    
   
   
   
9. SOEGAARD BALLESTER JM, Finn CB, Ginzberg SP, Kelz RR, et al
   Thyroid cancer pathologic upstaging: Frequency and related factors.
   Am J Surg. 2023;226:171-175.
   PubMed     Abstract available
   
   
   July 2023
10. SANDILOS G, Lou J, Butchy MV, Gaughan JP, et al
    Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
    Am J Surg. 2023;226:53-58.
    PubMed     Abstract available
    
    
    June 2023
11. WATANABE A, Wiseman SM
    Quality indicators for thyroid cancer care: What should surgeons know?
    Am J Surg. 2023;225:1108-1110.
    PubMed    
    
    
    
12. GOODSELL K, Ermer J, Amjad W, Swisher-McClure S, et al
    External beam radiotherapy for thyroid cancer: Patients, complications, and survival.
    Am J Surg. 2023;225:994-999.
    PubMed     Abstract available
    
    
    May 2023
13. MASHAT A, Hilzenrat R, Masoudi H, Walker B, et al
    The influence of papillary features on the risk of malignancy in thyroid nodules diagnosed as atypia of undetermined significance or follicular lesion of undetermined significance.
    Am J Surg. 2023;225:857-860.
    PubMed     Abstract available
    
    
    March 2023
14. ZHAO HH, Pickney C, Sarode AL, Kim-Mackow A, et al
    Varying impact of patient age on the rising rate of pediatric thyroid cancer: Analysis of NCDB database (2004-2017).
    Am J Surg. 2023;225:532-536.
    PubMed     Abstract available
    
    
    February 2023
15. LUFF MK, Kim J, Tseng CH, Livhits MJ, et al
    Racial/ethnic disparities in thyroid cancer in California, 1999-2017.
    Am J Surg. 2023;225:298-303.
    PubMed     Abstract available
    
    
    January 2023
16. BOBANGA I, Jin J, Wilhelm S, Sarode A, et al
    Primary hyperparathyroidism after radioactive iodine therapy: Is it a distinct clinical entity?
    Am J Surg. 2023;225:180-183.
    PubMed     Abstract available
    
    
    December 2022
17. SWANSON J, Littau M, Tonelli C, Cohn T, et al
    A matched cohort comparison of endoscopic resection, chemoradiation and esophagectomy in the treatment of early-stage esophageal squamous cell carcinoma.
    Am J Surg. 2022 Dec 2:S0002-9610(22)00782-6. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    November 2022
18. KITAJIMA T, Okugawa Y, Shimura T, Yamashita S, et al
    Combined assessment of muscle quality and quantity predicts oncological outcome in patients with esophageal cancer.
    Am J Surg. 2022 Nov 29:S0002-9610(22)00771-1. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    October 2022
19. HSIAO V, Hanlon BM, Robbins SE, Connor NP, et al
    Discovering domains important to health-related quality of life in differentiated thyroid cancer.
    Am J Surg. 2022;224:1176-1178.
    PubMed    
    
    
    September 2022
20. FUNG MMH, Lang BH
    A prospective study evaluating the use of low-dose intravenous sedation and analgesia during radiofrequency ablation of symptomatic, benign thyroid nodules.
    Am J Surg. 2022;224:928-931.
    PubMed     Abstract available
    
    
    August 2022
21. HARVEY A
    Using what we already have: Optimizing information from ultrasound and fine needle aspiration biopsy for decision making in thyroid nodular disease.
    Am J Surg. 2022;224:652.
    PubMed    
    
    
    
22. PAJAK C, Cadili L, Nabata K, Wiseman SM, et al
    (68)Ga-DOTATATE-PET shows promise for diagnosis of recurrent or persistent medullary thyroid cancer: A systematic review.
    Am J Surg. 2022;224:670-675.
    PubMed     Abstract available
    
    
    
23. DICKEY MV, Nguyen A, Wiseman SM
    Cancer risk estimation using American College of Radiology Thyroid Imaging Reporting and Data System for cytologically indeterminate thyroid nodules.
    Am J Surg. 2022;224:653-656.
    PubMed     Abstract available
    
    
    
24. SUJKA J, DuCoin CG
    Dr. Velanovich's contributions to understanding Barrett's Esophagus and its treatment.
    Am J Surg. 2022;224:821-822.
    PubMed    
    
    
    July 2022
25. STEINL GK, Stewart LA, McManus C, Lee JA, et al
    Ethanol ablation for the treatment of benign thyroid nodules.
    Am J Surg. 2022;224.
    PubMed     Abstract available
    
    
    
26. SUTTON W, Crepeau PK, Canner JK, Karzai S, et al
    Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
    Am J Surg. 2022;224.
    PubMed     Abstract available
    
    
    April 2022
27. TAKEDA E, Kimura J, Okabayashi T, Sui K, et al
    Clinicopathological features and surgical outcomes of pancreatic metastasis from thyroid cancer.
    Am J Surg. 2022 Apr 12. pii: S0002-9610(22)00237.
    PubMed     Abstract available
    
    
    
28. ZMIJEWSKI P, Kuo LE
    Can less Be more in the treatment of cN1a papillary thyroid microcarcinoma?
    Am J Surg. 2022;223:633-634.
    PubMed    
    
    
    
29. RAMONELL KM, Yip L
    The impact of race and ethnicity on thyroid nodules, malignancy risk, and surgical management.
    Am J Surg. 2022;223:615-616.
    PubMed    
    
    
    
30. ZHENG H, Lai V, Lu J, Kang JK, et al
    Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity.
    Am J Surg. 2022;223:617-623.
    PubMed     Abstract available
    
    
    
31. RAMONELL KM, Rentas C, Buczek E, Porterfield J Jr, et al
    Mediastinal parathyroidectomy: Utilization of a multidisciplinary, robotic-assisted transthoracic approach in challenging cases.
    Am J Surg. 2022;223:681-685.
    PubMed     Abstract available
    
    
    
32. MATSON J, Lwin TM, Bouvet M
    Rapid intraoperative perfusion assessment of parathyroid adenomas with ICG using a wide-field portable hand-held fluorescence imaging system.
    Am J Surg. 2022;223:686-693.
    PubMed     Abstract available
    
    
    February 2022
33. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00091.
    PubMed    
    
    
    
34. SHALABY M, Hadedeya D, Toraih EA, Razavi MA, et al
    Predictive factors of radioiodine therapy failure in Graves' Disease: A meta-analysis.
    Am J Surg. 2022;223:287-296.
    PubMed     Abstract available
    
    
    January 2022
35. KELLEY S, Beck AC, Weigel RJ, Howe JR, et al
    Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making.
    Am J Surg. 2022;223:76-80.
    PubMed     Abstract available
    
    
    December 2021
36. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2021 Dec 9. pii: S0002-9610(21)00724.
    PubMed     Abstract available
    
    
    October 2021
37. ARYANPOUR Z, Asban A, Boyd C, Herring B, et al
    A single institution experience with papillary thyroid cancer: Are outcomes better at comprehensive cancer centers?
    Am J Surg. 2021;222:802-805.
    PubMed     Abstract available
    
    
    September 2021
38. RAMONELL KM, Fazendin J
    The complex and heterogeneous entity of double adenomas in primary hyperparathyroidism.
    Am J Surg. 2021;222:481-482.
    PubMed    
    
    
    
39. GOODSELL KE, Ermer JP, Zaheer S, Kelz RR, et al
    Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?
    Am J Surg. 2021;222:483-489.
    PubMed     Abstract available
    
    
    
40. LIMBERG J, Stefanova D, Thiesmeyer JW, Ullmann TM, et al
    Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
    Am J Surg. 2021;222:562-569.
    PubMed     Abstract available
    
    
    August 2021
41. BACK K, Lee J, Choe JH, Kim JH, et al
    Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
    Am J Surg. 2021 Aug 12. pii: S0002-9610(21)00474.
    PubMed     Abstract available
    
    
    
42. SINCLAIR CF, Tellez MJ, Pelaez-Cruz R, Diaz-Baamonde A, et al
    Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety.
    Am J Surg. 2021;222:354-360.
    PubMed     Abstract available
    
    
    July 2021
43. MCDOW AD, Roman BR, Saucke MC, Jensen CB, et al
    Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
    Am J Surg. 2021;222:111-118.
    PubMed     Abstract available
    
    
    
44. MUSAVI LS, Fadavi D, He W, Sacks JM, et al
    Impact of payer status and hospital volume on outcomes after head and neck oncologic reconstruction.
    Am J Surg. 2021;222:173-178.
    PubMed     Abstract available
    
    
    June 2021
45. SCHWEITZER CL, Wiseman SM
    Adoption of intraoperative nerve monitoring for thyroidectomy: Supported by real-world NSQIP data.
    Am J Surg. 2021;221:1285-1290.
    PubMed    
    
    
    
46. WISEMAN SM, Saleh N, Tootooni A, Eshraghi P, et al
    Parathyroid identification during thyroid and parathyroid operations: A pilot study evaluating a novel low cost autofluorescence based device.
    Am J Surg. 2021;221:1150-1158.
    PubMed     Abstract available
    
    
    May 2021
47. ESCE AR, Redemann JP, Sanchez AC, Olson GT, et al
    Predicting nodal metastases in papillary thyroid carcinoma using artificial intelligence.
    Am J Surg. 2021 May 13. pii: S0002-9610(21)00281.
    PubMed     Abstract available
    
    
    
48. NYLEN C, Eriksson FB, Yang A, Aniss A, et al
    Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Am J Surg. 2021;221:886-892.
    PubMed     Abstract available
    
    
    April 2021
49. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2021;221:804-808.
    PubMed     Abstract available
    
    
    March 2021
50. BORTZ MD, Khokar A, Winchester DJ, Moo-Young TA, et al
    Radioactive iodine-125 seed localization as an aid in reoperative neck surgery.
    Am J Surg. 2021;221:534-537.
    PubMed     Abstract available
    
    
    
51. TAKEDA FR, Kodama Pertille Ramos MF, Pereira MA, Muniz RR, et al
    Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era.
    Am J Surg. 2021;221:631-636.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.